id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1991-P-0020-0003,FDA,FDA-1991-P-0020,FDACDER/ORP to Division of Dockets Management - Memorandum,Other,Memorandum,2012-02-23T05:00:00Z,2012,2,2012-02-23T05:00:00Z,,2012-02-23T20:33:31Z,,0,0,0900006480fbf21e
FDA-1991-P-0020-0001,FDA,FDA-1991-P-0020,Letter from FDA to Bass & Ullman on Behalf of National Association of Pharmaceutical Manufacturers,Other,Letter(s),1995-08-28T04:00:00Z,1995,8,,,2023-11-16T21:52:45Z,,0,0,09000064805284a2